Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis.
about
High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic ModelMultidrug-Resistant TB: Implementing the Right to Health through the Right to Enjoy the Benefits of Scientific Progress.Rationing tests for drug-resistant tuberculosis - who are we prepared to miss?Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis.An econometric method for estimating population parameters from non-random samples: An application to clinical case finding.Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.Towards new TB vaccines: What are the challenges?Diagnosis of opportunistic infections: HIV co-infections - tuberculosis.Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation.Performance of the Abbott RealTime MTB and MTB RIF/INH Assays in a Setting of High Tuberculosis and HIV Coinfection in South Africa.Drug-resistant tuberculosis in 2017: at a crossroads.Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria.Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.Epidemiology of Drug-Resistant Tuberculosis.Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis.Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey.Genetic polymorphism of human leucocyte antigen and susceptibility to multidrug-resistant and rifampicin-resistant tuberculosis in Han Chinese from Hubei Province.Mathematical Models for the Epidemiology and Evolution of Mycobacterium tuberculosis.Widespread use of incorrect PCR ramp rate negatively impacts multidrug-resistant tuberculosis diagnosis (MTBDRplus).Potential Application of Digitally Linked Tuberculosis Diagnostics for Real-Time Surveillance of Drug-Resistant Tuberculosis Transmission: Validation and Analysis of Test Results.Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations.Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.The relative fitness of drug-resistant : a modelling study of household transmission in PeruUsing routinely collected laboratory data to identify high rifampicin-resistant tuberculosis burden communities in the Western Cape Province, South Africa: A retrospective spatiotemporal analysisInvestigating spillover of multidrug-resistant tuberculosis from a prison: a spatial and molecular epidemiological analysisTuberculosis
P2860
Q28365057-E6C088A9-0172-4204-8FEF-F3CB78003C57Q30379233-48E28B42-F0C8-460C-891B-CE36766D4AAAQ30380955-CFA8CBDA-4A55-4C96-A847-96AE194260A6Q35966925-B3F3D5E3-EF6C-46D0-A590-CE5044C64C5BQ36205901-46A45AE1-9011-4A87-9B5D-8BAD3129760DQ37675764-30A94E5D-DF69-4992-AA76-0D73C695AA74Q38604010-1FC90E3F-65A2-4E07-95F1-D7B6AEED04F0Q38684466-63910091-6F02-49D2-A936-8CB9007A1987Q38767468-E3F195D7-A8F6-4974-8554-C5C2FF2ED72AQ39070206-A159DF2E-63FC-476F-93CC-6B011EB96F9DQ39129067-50C0DD90-86B5-40C4-819F-847DEDCCB542Q40168276-29C098CC-7858-4EE7-90B0-A1E6C61FBFCBQ40273120-5E8D9204-8A30-407B-93AF-DD2B4B18B6D9Q41677504-478CB3F0-CDFB-40BA-BB72-C83CFDBF0023Q42687193-1F0DA803-1B65-40A5-9E08-A4080632178FQ43923911-9A23AA6B-807D-48D9-914D-F88DCB337A64Q46277161-D4858AEB-24A5-4D55-84BD-F1E0890AF137Q46410213-D2F155FC-47AF-405E-BCE0-E5A3BEE67946Q46683653-4267FA52-7B12-41C8-92E4-2EABF8D706F3Q47344812-DBA83A2F-8879-4CB2-A341-D637B0B75271Q47369329-ADA4E23A-2FD4-411D-B6AD-8E560A08BE6DQ49912501-A7B3B78A-2128-4DA0-9982-86CC0E5F2530Q51784776-C0D66C20-E809-4486-AF8B-FA8301854C4EQ53766519-24FB9F2E-8ECC-4196-8622-949C1FE7F758Q54996259-6B5089DF-0CE1-4C58-A937-95681E7610DCQ56895151-E542D3D2-8B04-4FBA-BF4C-38C226F02611Q58731377-AA5FFB85-611F-4D57-BF86-BC8043A9789EQ58801357-42158AAF-FB98-4C2E-99CE-C9B10A8BF251Q59200569-094EA997-C227-4D78-AE2D-EABFB4B7D168
P2860
Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Burden of transmitted multidru ...... ansmission modelling analysis.
@ast
Burden of transmitted multidru ...... ansmission modelling analysis.
@en
type
label
Burden of transmitted multidru ...... ansmission modelling analysis.
@ast
Burden of transmitted multidru ...... ansmission modelling analysis.
@en
prefLabel
Burden of transmitted multidru ...... ansmission modelling analysis.
@ast
Burden of transmitted multidru ...... ansmission modelling analysis.
@en
P2860
P1476
Burden of transmitted multidru ...... ransmission modelling analysis
@en
P2093
David W Dowdy
P2860
P304
P356
10.1016/S2213-2600(15)00458-0
P577
2015-11-18T00:00:00Z